TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 199 filers reported holding TG THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,108,110 | -54.6% | 611,018 | +34.8% | 0.02% | -63.0% |
| Q2 2023 | $11,262,456 | +120.3% | 453,400 | +33.4% | 0.05% | +91.7% |
| Q1 2023 | $5,112,096 | +723.6% | 339,900 | +547.8% | 0.02% | +500.0% |
| Q4 2022 | $620,720 | -100.0% | 52,470 | +30.5% | 0.00% | -55.6% |
| Q3 2021 | $1,337,856,000 | +97.3% | 40,200 | +208.4% | 0.01% | +50.0% |
| Q4 2020 | $678,028,000 | – | 13,034 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |